Luye Pharma Group Ltd. (LYPHF)

Luye Pharma Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,400	1,051	1,796	1,666	1,617	1,513
Market Cap Growth	38.66%	-41.49%	7.80%	3.06%	6.88%	-38.28%
Enterprise Value	2,085	1,610	2,186	2,310	2,130	2,140
Last Close Price	0.38	0.34	0.43	0.75	0.75	-
PE Ratio	25.27	16.26	23.91	19.00	-	13.98
PS Ratio	1.63	1.26	2.07	1.92	1.98	1.78
PB Ratio	0.61	0.49	0.94	1.04	1.13	1.22
P/TBV Ratio	1.45	1.00	1.91	2.43	3.00	3.22
P/FCF Ratio	5.72	-	13.23	11.51	-	28.99
P/OCF Ratio	4.27	45.72	7.98	6.95	56.32	9.56
EV/Sales Ratio	2.41	1.94	2.52	2.66	2.60	2.52
EV/EBITDA Ratio	7.54	6.21	9.98	11.18	14.92	9.53
EV/EBIT Ratio	13.17	10.34	17.47	20.19	37.24	14.14
EV/FCF Ratio	8.52	-	16.10	15.96	-	41.02
Debt / Equity Ratio	0.72	0.66	0.62	0.83	1.04	1.23
Debt / EBITDA Ratio	5.98	5.38	5.33	6.27	10.09	6.68
Debt / FCF Ratio	6.77	-	8.75	9.12	-	29.30
Asset Turnover	0.21	0.22	0.25	0.26	0.24	0.28
Inventory Turnover	2.42	2.32	2.42	2.42	2.66	2.52
Quick Ratio	1.04	1.01	1.08	0.83	1.08	1.00
Current Ratio	1.31	1.24	1.32	1.14	1.42	1.38
Return on Equity (ROE)	3.68%	4.41%	4.39%	5.79%	-1.68%	8.26%
Return on Assets (ROA)	2.41%	2.58%	2.23%	2.11%	1.05%	3.09%
Return on Invested Capital (ROIC)	4.29%	4.93%	4.49%	4.96%	2.82%	5.62%
Return on Capital Employed (ROCE)	5.70%	6.00%	5.10%	5.30%	2.40%	7.40%
Earnings Yield	3.96%	6.15%	4.18%	5.26%	-1.31%	7.16%
FCF Yield	17.47%	-5.56%	7.56%	8.69%	-3.64%	3.45%
Payout Ratio	-	-	-	-	-	24.84%
Buyback Yield / Dilution	0.01%	-0.89%	-7.11%	-1.03%	-7.87%	0.85%
Total Shareholder Return	0.01%	-0.89%	-7.11%	-1.03%	-7.87%	0.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.